A new platinum anticancer drug forms a highly stereoselective adduct with duplex DNA

Angewandte Chemie - International Edition

Volumn 38, Issue 13-14, 1999, Pages 2060-2063

  Chen, Yu ^a   Parkinson, John A ^a   Guo, Zijian ^a   Brown, Tom ^b   Sadler, Peter J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Antitumor agents; Bioinorganic chemistry; DNA recognition; Platinum; Stereoselectivity

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL REACTION; COMPLEX FORMATION; DNA DETERMINATION; DRUG DNA BINDING; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0033549517     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(19990712)38:13/14<2060::AID-ANIE2060>3.0.CO;2-J     Document Type: Article

References (21)

1. R. P. Perez, Eur. J. Cancer 1998, 34, 1535-1542.
2. F. I. Raynaud, F. E. Boxall, P. M. Goddard, M. Valenti, M. Jones, B. A. Murrer, M. Abrams, L. R. Kelland, Clin. Cancer Res. 1997, 3, 2063-2074.
3. J. Holford, S. Y. Sharp, B. A. Murrer, M. Abrams, L. R. Kelland, Br. J. Cancer 1998, 77, 366-373.
4. Y. Chen, Z. Guo, S. J. Parsons, P. J. Sadler, Chem. Eur. J. 1998, 4, 672-676.
5. Y. Chen, Z. Guo, J. A. Parkinson, P. J. Sadler, J. Chem. Soc. Dalton Trans. 1998, 3577-3585.
6. 15N) = 4.84/ -65.12, 4.82/ - 65.03, 4.69/ - 65.12, 4.65/ - 65.25 (partially overlapped with water, relative intensities: approximately 2:2:3:3).
7. J. A. Parkinson, Y. Chen, Z. Guo, S. J. Berners-Price, T. Brown. P. J. Sadler, unpublished results. The cisplatin G*G* chelate of duplex 2 has essentially the same structural characteristics as the platinated 12-mer DNA duplex d(CCTCTG*G*TCTCC) - (GGAGACCAGAGG) reported by Gelasco and Lippard.[8]
8. A. Gelasco, S. J. Lippard, Biochemistry 1998, 37, 9230-9239.
9. C. Giessner-Prettre, B. Pullman, Biochem. Biophys. Res. Commun. 1976, 70, 578-581.
10. J. A. Parkinson, S. E. Ebrahimi, J. H. McKie, K. T. Douglas, Biochemistry 1994, 33, 8442-8452.
11. A. H. Krotz, L. Y. Kuo, T. P. Shields, J. K. Barton, J. Am. Chem. Soc. 1993, 115, 3877-3882.
12. T. W. Hambley, Coord. Chem. Rev. 1997, 166, 181-223.
13. M. J. Bloemink, R. J. Heetebrij, K. Inagaki, Y. Kidani, J. Reedijk, Inorg. Chem. 1992, 31, 4656-4661.
14. J. F. Hartwig, S. J. Lippard, J. Am. Chem. Soc. 1992, 114, 5646-5654.
15. S. U. Dunham, S. U. Dunham, C. J. Turner, S. J. Lippard, J. Am. Chem. Soc. 1998, 120, 5395-5406.
16. C. Bauer, T. Peleg-Shulman, D. Gibson, A. H.-J Wang, Eur. J. Biochem. 1998, 256, 253-260.
17. F. Reeder, Z. Guo, P. del S. Murdoch, A. Corazza, T. W. Hambley, S. J. Berners-Price, J.-C. Chottard, P. J. Sadler, Eur. J. Biochem. 1997, 249, 370-382.
18. T. Matsumoto, K. Endoh, K. Akamatsu, K. Kamisango, H. Mitsui, K. Koizumi, K. Morikawa, M. Koizumi, T. Matsuno, Br. J. Cancer 1991, 64, 41-46.
19. E. Cvitkovic, Br. J. Cancer 1998, 77, 8-11.
20. S. J. Barton, K. J. Barnham, A. Habtemariam, R. E. Sue, P. J. Sadler, Inorg. Chim. Acta 1998, 273, 8-13.
21. P. M. Takahara, C. A. Frederick, S. J. Lippard, J. Am. Chem. Soc. 1996, 118, 12 309-12 321.